1WHO Dept of Noncommunicable Disease surveillance Geneva 1999糖尿病的诊断与分类.中国糖尿病杂志,2000,8(1):5-6.
2David M,Natha N,John B,et al.Medical management of hyperglycemia in type 2 Diabete:A consensus algorithm for the initiation and adjustment of therapy[J].Diabetes Care,2008,31(12):1-11.
3Lindscy Rcihhart,Chad A.Panning,insulin glargin c:A new bngacting insulin product[J].Am J Health Stst Pham,2002,59:643-649.
2KLONOFF DC. Continuous glucose mouitoring: roadmap for 21st century diabetes therapy[ J ]. Diabetes Care ,2005,28 (5) :1231 -1239.
3DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GiOUP. The effect of intensive treatment of diabetes on the development and long time complications in insulin dependent diabetes mellitus [ J ]. N Engl J Med, 1993,329 ( 14 ) : 977 - 986.
4UK PROSPECTIVE DIABETES STUDY ( UKPDS ) GROUP. Intensive blood glucose control with sulphonylureas or insulin compared with type 2 diabetes [ J. Lancet, 1998,352 ( 9131 ) :837-853.
5Manuel Gonz61ez-Ortiz,Jesds F.Guerrero-Romero,Rafael Violante-Ortiz Efficacy of glimepiride/metformin combination versus glibenclamide/met- forrnin in patients with uncontrolled type 2 diabetes mellitus Journal of Diabetes and Its Complications[J].Diabetes Complicat,2009,23(6):376- 379.
6Huibert Hendrik Ponssen,Jan Willem Frederik Ehe,Philippe Lehert Combined Metfonnin and Insulin Therapy for Patients with vpe 2 Dia- betes Mellitus[J].CLINICAL THERAPEUTICS/VOL,2000,22(6):709-7 ! 8.
7White RD.The treat- to- target Alc approach to control type 2 diabetes and prevent complications[J].Adv Ther, 2007,24(3) :545.
8David M,NathaN,John B,et al.Medical management of hype ycemia in type 2 Diabete:A co nsensus algorithm for the initiation and adjust- ment of therapy[J].Diabetes Care, 2008,31 (12): 1-11.
